BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 12128286)

  • 1. The role of lifestyle modification in polycystic ovary syndrome.
    Norman RJ; Davies MJ; Lord J; Moran LJ
    Trends Endocrinol Metab; 2002 Aug; 13(6):251-7. PubMed ID: 12128286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lifestyle modification in polycystic ovarian syndrome.
    Moran LJ; Brinkworth G; Noakes M; Norman RJ
    Reprod Biomed Online; 2006 May; 12(5):569-78. PubMed ID: 16790100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.
    Brennan L; Teede H; Skouteris H; Linardon J; Hill B; Moran L
    J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
    Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
    Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I
    Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of obesity in the development of polycystic ovary syndrome.
    Motta AB
    Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Norman RJ; Teede HJ
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007506. PubMed ID: 21328294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM
    Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and polycystic ovary syndrome.
    Vrbikova J; Hainer V
    Obes Facts; 2009; 2(1):26-35. PubMed ID: 20054201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review.
    Anwar S; Shikalgar N
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S913-S917. PubMed ID: 28711517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes.
    Ortiz-Flores AE; Luque-Ramírez M; Escobar-Morreale HF
    Expert Opin Pharmacother; 2018 Dec; 19(17):1915-1926. PubMed ID: 30289728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
    Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome, obesity and reproductive implications.
    Hirschberg AL
    Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.
    Balen AH; Morley LC; Misso M; Franks S; Legro RS; Wijeyaratne CN; Stener-Victorin E; Fauser BC; Norman RJ; Teede H
    Hum Reprod Update; 2016 Nov; 22(6):687-708. PubMed ID: 27511809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative possibilities influencing PCOS syndrome - the importance of nutrition.
    Líška Dávid; Záhumensky Jozef
    Ceska Gynekol; 2021; 86(5):343-348. PubMed ID: 34736334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.